AXA (OTCMKTS:AXAHY) Rating Lowered to Hold at Zacks Investment Research

Zacks Investment Research lowered shares of AXA (OTCMKTS:AXAHY) from a buy rating to a hold rating in a research report released on Friday, Zacks.com reports.

According to Zacks, “The AXA Group is an international group of insurance and related financial services companies. AXA’s insurance operations are diverse geographically, with activities in 50 countries, principally Western Europe, North America and the Asia/Pacific area. In the United States, AXA is represented through its 60% holding in The Equitable companies and its subsidiaries, Equitable Life, Alliance Capital management and Donaldson, Lufkin & Jenrette. “

Other research analysts have also issued research reports about the company. Barclays raised AXA from an equal weight rating to an overweight rating in a research report on Wednesday, December 4th. ValuEngine lowered AXA from a hold rating to a sell rating in a research report on Wednesday, November 6th.

AXAHY stock traded down $0.10 on Friday, reaching $27.55. 65,469 shares of the company traded hands, compared to its average volume of 66,261. AXA has a one year low of $20.84 and a one year high of $28.00. The company has a market cap of $66.54 billion, a P/E ratio of 9.03, a price-to-earnings-growth ratio of 1.57 and a beta of 1.07. The firm has a fifty day simple moving average of $27.27 and a 200-day simple moving average of $25.72.

About AXA

AXA SA, through its subsidiaries, provides insurance and asset management services worldwide. It operates in seven segments: France, Europe, Asia, AXA XL, the United States, International, and Transversal & Central Holdings. The company offers a range of insurance products, including life and savings, property and casualty, and health.

See Also: What does a bar chart mean for investors?

Get a free copy of the Zacks research report on AXA (AXAHY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for AXA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AXA and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit